lansoprazole has been researched along with Pre-Eclampsia in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
de Alwis, N | 1 |
Beard, S | 1 |
Binder, NK | 1 |
Pritchard, N | 1 |
Tong, S | 1 |
Kaitu'u-Lino, TJ | 1 |
Hannan, NJ | 1 |
1 other study available for lansoprazole and Pre-Eclampsia
Article | Year |
---|---|
Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors.
Topics: Antioxidants; Esomeprazole; Female; Humans; Hypoxia; Infant, Newborn; Lansoprazole; Microfilament Pr | 2022 |